MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Nexalin Technology, Inc. Common Stock

NXL

#3852
Nexalin Technology, Inc. Common Stock
0.47
-9.62%
Sector:
Base:
Profit Currency:
Daily Range
0.47
0.47
Year Range
0.37
2.79
Daily Change
-9.62%
Monthly Change
-24.19%
6 month change
-42.68%
Year Change
-82.91%
Previous Close
0.52
Open
0.47
Bid
Ask
Low
0.47
High
0.47
Volume
5
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. NXL
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202220232024 TTM

News

Benzinga Benzinga
NXL
2026.02.24
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Nexalin Technology (NASDAQ:NXL)
Investing Investing
NXL
2026.02.22
Nuix 1H26 presentation: Neo platform surges 148%, cash flow turns positive
Investing Investing
NXL
2026.02.22
Earnings call transcript: Nuix Ltd reports strong H1 2026 growth amid Neo platform expansion
Investing Investing
NXL
2026.02.05
Nexalin Technology stock rises after launching AI-powered virtual clinic
Benzinga Benzinga
NXL
2026.02.05
EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings - Nexalin Technology (NASDAQ:NXL)
Investing Investing
NXL
2026.02.02
Nexalin reports brain imaging studies validate its neurostimulation tech
Investing Investing
NXL
2026.01.23
Nexalin receives Nasdaq minimum bid price deficiency notice
Investing Investing
NXL
2025.12.03
Nexalin advances Alzheimer’s device after FDA meeting
Investing Investing
NXL
2025.12.03
Nexalin Technology earnings missed by $0.01, revenue fell short of estimates
Investing Investing
NXL
2025.11.13
Nexalin signs exclusive distribution deal for neurostimulation device in Israel
Investing Investing
NXL
2025.11.05
FDA accepts Nexalin’s submission for Alzheimer’s treatment device
Investing Investing
NXL
2025.10.30
Nexalin’s neurostimulation device receives approval in Israel

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd